Search results

Public procurement of medicines in Russia totaled 1 trillion rubles in 2025, representing a 26% increase compared with 2024. In physical terms, procurement volumes grew 27% year-on-year to 746 million packages. These figures were presented by Sergey Shulyak, CEO of DSM Group, at the PharmLiga forum in Moscow, GxP News reported. Oncology drugs accounted for…

The value of Russia’s retail pharmaceutical market reached 1.83 trillion rubles in 2025, marking a 13.3% increase year-on-year, according to the press service of the Center for the Development of Advanced Technologies (CRPT), the operator of the national product labeling system. At the same time, sales in physical terms totaled 4.7 billion packages, which is…

The compounds could help develop antimicrobial, anticancer, and anti-inflammatory drugs, according to the press service of Reshetnev University in Krasnoyarsk. Scientists at Reshetnev University in Krasnoyarsk have synthesized ten new chemical compounds that could serve as the basis for the development of innovative medicines and materials with unique properties. In particular, these compounds may help…

According to data from DSM Group, the pharmaceutical market volume at distributor prices reached 2.87 trillion rubles in 2025, representing a 19% increase compared to 2024. The main driver of growth was the public sector, which expanded by 26% year-on-year, largely due to increased deliveries to healthcare institutions under contracts signed at the end of…

The strategy for developing the bioeconomy sector предусматривает создание новых рынков, включая синтетическую биологию, промышленную микробиологию, биополимеры, биотопливо и продукты питания нового поколения, сообщил глава Минпромторга Антон Алиханов. Russia plans to reduce its dependence on imports of critical biotechnological components—such as enzymes, starter cultures, and certain types of protein products—by at least half by 2030.…

By 2030, Russia plans to build at least 10 new pharmaceutical manufacturing facilities, Russian Minister of Industry and Trade Anton Alikhanov said at a meeting between President Vladimir Putin and members of the government. “The industrial base of the sector has largely been formed. By 2030, it is planned to build at least 10 additional…

The share of domestically produced medicines in Russia stands at 63%, and exceeds 80% in government procurement, Russian Minister of Industry and Trade Anton Alikhanov reported at a meeting attended by Russian President Vladimir Putin devoted to the results of the December “Direct Line.” “The expansion of production capacity has enabled us to reach a…

The special procedure for the sale in Russia of registered foreign medicinal products will remain in effect until December 31, 2027, according to the government’s press service. The measure concerns the possibility of selling foreign medicines in their original foreign packaging. “At the same time, the label must be in Russian,” the statement says. The…

Russian scientists have developed a drug for the treatment of hepatitis B based on CRISPR/Cas9 technology. A hepatitis B therapy based on gene-editing technology has been developed in Russia, Sechenov University reported. “We have developed a new non-viral delivery system based on biodegradable nanoparticles. For the first time, we have learned how to package CRISPR/Cas…

Starting July 1, 2026, Government Resolution of the Russian Federation No. 1392 dated September 10, 2025, “On Amendments to Government Resolution of the Russian Federation No. 719 dated July 17, 2015,” will enter into force. The resolution introduces a points-based system for determining the country of origin of pharmaceutical products. To implement this resolution, the…